X-linked inhibitor of apoptosis protein (XIAP) is a potent suppressor of apoptotic cell death, which functions by directly inhibiting caspases, the principal effectors of apoptosis. Here we report that XIAP can also function as a cofactor in the regulation of gene expression by transforming growth factor-␤ (TGF-␤). XIAP, but not the related proteins c-IAP1 or c-IAP2, associated with several members of the type I class of the TGF-␤ receptor superfamily and potentiated TGF-␤-induced signaling. Although XIAP-mediated activation of c-Jun N-terminal kinase and nuclear factor B was found to require the TGF-␤ signaling intermediate Smad4, the ability of XIAP to suppress apoptosis was found to be Smad4-independent. These data implicate a role for XIAP in TGF-␤-mediated signaling that is distinct from its anti-apoptotic functions.
Apoptosis is an evolutionarily conserved process that plays a critical role during development and tissue homeostasis, and also serves to remove damaged or extraneous cells from an organism (1) (2) (3) . Apoptotic cells undergo a regulated autodigestion, which involves the disruption of cytoskeletal integrity, cell shrinkage, nuclear condensation, and the activation of endonucleases. The chief effectors of the apoptotic cell death pathway are the caspase family of cysteine proteases. Caspases are synthesized as inactive precursors that are cleaved at specific aspartate residues to generate the active subunits. Zymogen cleavage can occur by several mechanisms including proximityinduced autoprocessing or cleavage by other caspases, revealing a caspase cascade with upstream initiator caspases such as caspases -8, -9, and -10 and downstream, effector caspases, such as caspases-3, -6, and -7 (4, 5) . The activity of these caspases is regulated by several families of both pro-and antiapoptotic cellular proteins including the inhibitor of apoptosis (IAP) 1 proteins (6).
The IAPs were first discovered in the genomes of baculoviruses, where they were found to maintain viability of virus infected cells and thus enhance virus replication (7, 8) . Certain baculovirus IAPs can function in mammalian cells to suppress apoptosis (9, 10) , and IAP-related genes have subsequently been identified in many metazoan genomes (11) , indicating a high degree of evolutionary conservation. IAPs are defined by a domain of ϳ70 amino acids known as the baculovirus IAP repeat (BIR) (7, 11) . Members of the IAP family contain one to three imperfect BIR repeats arranged in tandem. These BIR domains are required for the ability of IAPs to suppress apoptosis, and have been shown to bind caspases directly (6) . The mammalian IAP family (6) includes c-IAP1, c-IAP2, X-linked IAP (XIAP), neuronal apoptosis inhibitory protein (NAIP), survivin, BRUCE, and ML-IAP (12) . Of these, c-IAP1, c-IAP2, and XIAP exhibit the most structural homology, possessing three tandem BIR repeats and a C-terminal RING finger, which is involved in ubiquitin conjugation (13) .
XIAP (14) , also known as ILP (9) , or MIHA (15) , is a broadranging suppressor of apoptosis (14, 16) . XIAP has been shown to bind to and directly inhibit the activity of specific caspases (17, 18) . However, emerging data suggest that the cellular activities of XIAP are not limited to caspase binding and inhibition. A previous report (19) implicated XIAP in the regulation of the stress-induced kinase, c-Jun N-terminal kinase (JNK). Similarly, XIAP has recently been identified as an activator of nuclear factor B (NF-B), a pleiotropic transcription factor that regulates expression of a range of acute phase and immediate-early genes (20) . Other members of the IAP family have also been implicated in signal transduction. For example, c-IAP1 and c-IAP2 associate with the type 2 tumor necrosis factor receptor (TNFR2) signaling machinery (21, 22) through physical interactions with members of the TNFR-associated factors (TRAFs). The TRAFs and c-IAPs are therefore thought to be signal transduction intermediates that are involved in JNK and NF-B activation (23) (24) (25) . However, XIAP does not interact with any of the known TRAF proteins or with any other components of the TNFR2 signaling pathway (16, 26) , suggesting that XIAP plays a role in the cell that is separate from those of c-IAP1 or c-IAP2.
Several members of the IAP family have been reported to be involved in signaling cascades that are unrelated to the tumor necrosis factor pathway. For example, the Drosophila IAPs, dIAP-1 and dIAP-2/dILP, are known to interact with Thickveins (Tkv), a type I serine-threonine kinase receptor homologous to the bone morphogenetic protein (BMP) type I receptor (27) . XIAP has been implicated in BMP signaling (28) as a bridging molecule between the BMP type I receptor and a downstream signaling molecule, TGF-␤-activated kinase-binding protein 1 (TAB1).
The TGF-␤ superfamily encodes a group of cytokines that includes BMP, TGF-␤, and the activins/inhibins, and is involved in diverse cellular responses such as apoptosis, differentiation, and cell cycle arrest (29, 30) . Signaling initiated by this family of cytokines involves two classes of receptors. The type II receptors bind their specific ligand and then phosphorylate a type I receptor (31, 32) , which propagates the signal through a specific subset of the Smad family of signal transduction intermediates and transcription factors (33, 34) . One of these intermediate signaling proteins, Smad4, is common to all of these signaling pathways in that it serves as the obligatory partner of the pathway-restricted Smad proteins and, together with them, translocates to the nucleus to regulate gene expression by binding to cognate sites in the promoters of target genes (35, 36) .
Interestingly, both TGF-␤ and XIAP have been reported to specifically activate JNK (19, 37) . Furthermore, Smad proteins have been shown to cooperate with the AP-1 transcription factor, a heterodimer of c-Fos and c-Jun that binds specific sequences in its target promoters (38) . AP-1 activity is stimulated by phosphorylation of the c-Jun transactivation domain by JNK (38, 39) . Moreover, recent data have shown a direct, TGF-␤-inducible interaction between Smad3 and c-Jun (36) . Because both TGF-␤ and XIAP can activate JNK, and the TGF-␤ and JNK signaling pathways are closely linked, we examined the possibility of a role for XIAP in TGF-␤-mediated signaling.
Data presented here reveal the involvement of XIAP in signaling through the TGF-␤ type I receptor (T␤RI). XIAP was found to co-localize with T␤RI and to interact with this receptor. XIAP also activated transcription of both TGF-␤-and Bresponsive promoters. Furthermore, the signaling properties of XIAP were found to be distinct from its anti-apoptotic properties in that signaling by XIAP was inhibited by a dominant negative mutant of Smad4, whereas its anti-apoptotic properties were unaffected by dominant negative Smad4. These data suggest that XIAP is involved in both caspase inhibition and signaling through the T␤RI receptor.
EXPERIMENTAL PROCEDURES
Plasmids-The pEBB expression vector has been described previously (40) , and the pEBB-Flag, pEBB-HA, and pEBB-T7 expression vectors are all derivatives of pEBB that have been modified to incorporate the appropriate epitope tag and translational termination codes in all three reading frames. The full-length, ⌬RING, and 3xBIR XIAP vectors were generated by subcloning into pEBB or one of its epitopetagged derivatives, as described previously (16) . The pEBG mammalian glutathione S-transferase (GST) fusion vector (41) was kindly provided by Dr. B. Mayer. The GST-XIAP/hILP, GST-c-IAP1, and GST-c-IAP2 fusion proteins have been previously described (16) . Deletions of XIAP were subcloned into pEBG in-frame with the GST reading frame to generate pEBG-⌬RING and pEBG-3xBIR.
The 2B-luc reporter construct has been described previously (42) . The 3TP-Lux reporter was kindly provided by Dr. J. Massagué. The wild type and dominant negative Smad4 (⌬M4) constructs were gifts of Dr. M. de Caestecker. The HA-tagged expression vectors encoding wild type, constitutively active (T204D), and kinase-deficient (K232R) T␤RI receptors, as well as the constitutively active ALK mutants, were gifts from Dr. J. Wrana and Dr. L. Attisano. The Bax expression vector was kindly provided by Dr. S. Korsmeyer. The HA-JNK expression vector was a gift from Dr. M. G. Sanna.
The full-length open reading frame of TAK1 was amplified by polymerase chain reaction utilizing the following two primers: 5Ј-ATA-GGATCCATGTCTACAGCCTCTGCCGCCTCC-3Ј and 5Ј-ATTATCGA-TATTTCAAAATGTAACGGTCCCAGAGAATC-3Ј using standard conditions. The polymerase chain reaction product was cloned into pCR2.1 (Invitrogen, Carlsbad, CA) and subcloned into pEBB-T7. This clone was sequenced in its entirety and found to be identical to human TAK1a (43) . The K63W dominant negative mutant (DN TAK1) was constructed by site-directed mutagenesis using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA), and was confirmed by sequencing.
Cells and Transfections-Human embryonic kidney 293 cells and HeLa (human adenocarcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). HepG2 cells (ATCC, Manassas, VA) were maintained in Eagle's medium containing Earle's salts (EMEM) with 10% FBS. All media were supplemented with 2 mM glutamine, and all cells were maintained at 37°C in 5% CO 2 .
Transfection of 293 cells was performed by the calcium phosphate precipitation procedure as described previously (44) . HepG2 cells were transfected using LipofectAMINE reagents (Life Technologies, Inc.) using 10 l of LipofectAMINE with 200 l of serum-free DMEM for each well of a six-well plate, for 5 h. Following transfection, the medium was changed to EMEM with 10% FBS, and cells were incubated for 16 h. The medium was then changed to EMEM ϩ 0.2% FBS with or without 5 ng/ml TGF-␤ and allowed to incubate for another 24 h. Transfection of HeLa cells was performed as described above, except that 6 l of LipofectAMINE was incubated for 3 h, and following transfection, the medium was changed to DMEM with 10% FBS and incubated for 16 h prior to harvest.
Luciferase Assays-For 3TP-Lux reporter assays, cells were transfected with 200 ng/well reporter plasmid together with 2 g/well indicated expression vector, in a six-well plate. For 2B-luc reporter assays, 50 ng/well reporter was transfected along with 2 g/well indicated expression vectors. Cells were transfected for 6 -8 h, after which time the medium was replaced with fresh DMEM ϩ 10% FBS and cells were incubated for 16 h. In all transfections, the amount of DNA was kept constant by the addition of an empty control vector.
Cells were harvested by washing once in phosphate-buffered saline (PBS) and then lysing in 0.5 ml of 1ϫ reporter lysis buffer (Promega, Madison, WI) according to the manufacturer's specifications. Luciferase activity was quantified using the Luciferase Assay System (Promega, Madison, WI) on a Tropix TR717 microplate luminometer (PE Applied Biosystems, Bedford, MA). All assays were performed in triplicate, and all data shown are representative of at least three independent experiments.
GST Coprecipitations-293 cells were transiently transfected with a total of 10 g of plasmid DNA in a 10-cm dish. Following transfection, cells were washed once in 5 ml of PBS and lysed for 10 min at room temperature in 1.0 ml of 1% Triton X-100 buffer (45) . Following lysis, 400 l of lysate were incubated with 20 l of a 50% slurry of glutathione-Sepharose beads (Amersham Pharmacia Biotech) in Triton X-100 buffer for 1 h at 4°C. Beads were then washed four times with 1 ml of Triton X-100 lysis buffer and analyzed by immunoblotting.
Immunoblotting-Proteins were resolved by sodium dodecyl sulfate (SDS) 4 -12% gradient gel electrophoresis in 1ϫ MOPS buffer (Invitrogen, Carlsbad, CA) and transferred to nitrocellulose membranes by electrophoretic blotting transfer buffer (Invitrogen) containing 20% methanol. The membrane was blocked for 1 h in Tris-buffered saline with 0.2% Tween (TBS-T) and 5% milk. Proteins were visualized by incubation with a 1:1000 dilution of primary antibody in TBS-T with 5% milk for 1 h, followed by secondary incubation with horseradish peroxidase-conjugated secondary antibody (1:2000) in TBS-T with 5% milk for 1 h. The blot was washed twice for 10 min and once for 30 min in TBS-T and resolved using the enhanced chemiluminescence (ECL) Western blotting detection system (Amersham Pharmacia Biotech). Primary antibodies used were anti-HA antibody (Mono HA.11; Covance, Berkeley, CA), anti-GST (Santa Cruz, Santa Cruz, CA), anti-Myc (9E10; Covance, Berkeley, CA), anti-T7 tag (horseradish peroxidaseconjugated; Novagen, Madison, WI), anti-hILP (H59520; Transduction Laboratories, San Diego, CA).
Immunofluorescence-HepG2 cells were plated at 1 ϫ 10 5 cells/well onto sterilized glass coverslips (Corning, Charlotte, NC), incubated for 16 h, and transiently transfected with the indicated plasmids. Cells were washed once in PBS, fixed in 3.5% paraformaldehyde for 5 min, permeabilized with 0.5% Triton X-100 in PBS for 10 min, washed once in PBS, and blocked in 10% goat serum in PBS for 30 min at room temperature. Cells were then incubated for 30 min at room temperature with either of the following primary antibodies: anti-hILP/XIAP mouse monoclonal antibody (Transduction Laboratories, San Diego, CA) or rabbit anti-HA polyclonal antibody (1:200, sc-805, Santa Cruz, Santa Cruz, CA). Cells were washed three times with PBS prior to incubation with the second primary antibody and then incubated for 30 min with the following secondary antibodies: fluorescein isothiocyanate-conjugated goat anti-mouse antibody (1:1000, Kirkegaard & Perry, Gaithers-burg, MD) or rhodamine-conjugated goat anti-rabbit antibody (1:1000, Jackson Immunoresearch, West Grove, PA) in PBS with 10% goat serum. Cells were mounted with medium containing 4,6-diamidino-2-phenylindole (Vectashield mounting medium H-1000, Vector Laboratories, Burlingame, CA) and then visualized with a Zeiss confocal microscope.
Kinase Assays-293 cells were transiently transfected with 0.5 g of HA-tagged JNK and 2 g of the indicated plasmid in a six-well plate. Following 18 h of incubation, cells were lysed in 0.3 ml of M2 buffer (19) on ice for 30 min. For assays involving p38 inhibitors, cells were treated with 50 M SB203580 or 30 M SB202190 (Calbiochem, La Jolla, CA) and allowed to incubate for 24 h prior to lysis. Protein concentrations were standardized by the method of Bradford (46) using a commercial kit (Bio-Rad) followed by immunoprecipitation of HA-JNK with protein A-Sepharose and a monoclonal anti-HA antibody (12CA5, Roche Molecular Biochemicals) for 1 h at 4°C. In vitro kinase assays were performed exactly as described (23) . Activation of JNK was measured as phosphorylation of GST-c-Jun. Expression of HA-JNK, XIAP, Myc-DN Smad4, and T7-DN TAK1 was confirmed by immunoblotting.
Caspase Assays-293 cells were transiently transfected with 2 g of the indicated expression vector along with 0.5 g of a Bax expression vector in a six-well plate. Following 16 h of incubation at 37°C, the cells were harvested and resuspended in 100 l of caspase assay cell lysis buffer (BIOSOURCE, Camarillo, CA). These cells were lysed for 10 min at room temperature with gentle rocking, and the cell debris was removed by centrifugation for 5 min at 14,000 rpm in an Eppendorf microcentrifuge. Protein concentrations were standardized, and caspase assays were performed using the ApoTarget protease assay (BIOSOURCE) according to the manufacturer's specifications. Samples were read every 5 min for 2 h on a Cytofluor 4000 fluorescence plate reader (Perseptive Biosystems, Framingham, MA) with an excitation wavelength of 400 nm and an emission wavelength of 508 nm.
RESULTS

XIAP Associates with the TGF-␤ RI
Receptor-To explore the possibility that XIAP might associate with members of the TGF-␤ receptor superfamily, constitutively active mutant members of the TGF-␤ type I receptor superfamily were cotransfected with a mammalian GST-XIAP expression vector into human embryonic kidney 293 cells. Cell lysates were precipitated with glutathione-Sepharose beads, and associated receptors were detected by immunoblot analysis. XIAP was found to coprecipitate with several members of the receptor superfamily, most notably TSR1 (ALK1), activin RIb (ALK4), and TGF-␤ RI (ALK5) receptors (Fig. 1A) . Weaker interactions were also observed between GST-XIAP and activin RI (ALK2) and BMP RIa (ALK3) receptors upon longer exposures (data not shown). The BMP RIb (ALK6) receptor did not coprecipitate with XIAP.
To determine whether the activation state of T␤RI affected its interaction with XIAP, constitutively active (ALK5*), wild type T␤RI (ALK5), and kinase-deficient T␤RI (ALK5 kinasedeficient) were compared for their ability to associate with XIAP in 293 cells. XIAP was found to interact equivalently with all versions of T␤RI (Fig. 1B) , indicating that the receptor need not be activated to interact with XIAP.
Since there are currently no antibodies available to allow the detection of endogenous T␤RI, immunofluorescence analysis was performed on HepG2 cells transfected with expression vectors encoding both XIAP and HA-tagged T␤RI, in order to confirm the interaction between T␤RI and XIAP. Transfected cells were visualized by confocal microscopy. XIAP and T␤RI were observed to co-localize predominantly in the cytoplasm (Fig. 2) , although interestingly a small proportion of XIAP was detected in the nucleus of transfected cells. These data provide further evidence for an interaction between these proteins.
To further explore the possibility of nuclear localization or translocation of XIAP, immunofluorescence analysis was performed on several cell lines transfected with epitope-tagged XIAP and subsequently treated with either a media control, or media containing TGF-␤. The subcellular localization of XIAP was observed by confocal microscopy, and no change in localization was seen upon treatment with TGF-␤ (data not shown).
To determine whether other IAP family members, in addition to XIAP, could interact with T␤RI, coprecipitations were performed with several members of the IAP family (XIAP, c-IAP1, and c-IAP2) and T␤RI. T␤RI was found to coprecipitate with GST-XIAP, but not with the other IAP family members or with the GST control vector (Fig. 3A) . These data suggest that T␤RI associates specifically with XIAP.
XIAP contains three N-terminal BIR domains and a C-terminal RING finger, separated by an amphipathic spacer region (6). The BIR domains are involved in caspase binding and inhibition (17, 18, 47, 48) , whereas the C-terminal RING finger can promote E2-dependent ubiquitination (13, 49 -51) . To determine which domains of XIAP are involved in binding the T␤RI receptor, sequential deletions of the C-terminal domains of XIAP fused to the mammalian GST protein were utilized in coprecipitation experiments. A weak interaction was detected between T␤RI and the XIAP ⌬RING construct, while a strong interaction was observed between T␤RI receptor and the 3xBIR domain of XIAP, which lacks both the RING finger and the spacer region (Fig. 3B) . These data suggest that the XIAP-T␤RI interaction involves the BIR domain of XIAP.
XIAP Activates Transcription from TGF-␤-responsive Promoters-Since an interaction between XIAP and T␤RI was observed, the possibility was tested that XIAP might be involved in regulating transcription from TGF-␤-responsive promoters. Several cell lines were examined to determine whether XIAP could activate a TGF-␤-responsive reporter, 3TP-Lux, which contains TGF-␤-responsive elements of the plasminogen activator inhibitor-1 (PAI-1) and collagenase promoters (31) . Transient transfection of XIAP into either 293 cells, HepG2 cells, or HeLa cells resulted in activation of the 3TP-Lux reporter (Fig. 4A) , with the most significant activation seen in the 293 cell line.
To determine which domains of XIAP are involved in activation of the 3TP-Lux reporter, 293 cells were transiently transfected with the 3TP-Lux reporter and expression vectors containing HA-tagged XIAP or sequential C-terminal deletions of XIAP. Whereas the full-length XIAP activated transcription from the 3TP-Lux reporter, the ⌬RING and 3xBIR constructs were unable to do so (Fig. 4B) , suggesting that the C-terminal RING domain of XIAP is required for this activity.
The effect of XIAP on TGF-␤-mediated activation of 3TP-Lux was then examined by utilizing the HepG2 cell line since this line is known to express T␤RI. TGF-␤ stimulation activated transcription directed by the 3TP-Lux reporter plasmid ϳ5-fold (Fig. 4C) , whereas transient transfection with XIAP in addition to TGF-␤ stimulation activated transcription ϳ20-fold. These data suggest that XIAP and TGF-␤ can cooperatively activate transcription of TGF-␤-responsive genes.
Activation of 3TP-Lux by XIAP Is Smad4-dependent, but TAK1-independent-TGF-␤-mediated signal transduction is initiated by phosphorylation of T␤RI by T␤RII in response to ligand binding (31) . The activated receptor complex can then activate one of several pathway-specific Smad proteins, which have recently been identified as the main cytoplasmic transducers in this pathway (33, 34) . These Smad proteins, once activated, form a complex with the common mediator of TGF-␤ signal transduction, Smad4 (29) , which then translocates to the nucleus and regulates gene expression. To investigate whether XIAP signaling was Smad4-dependent, 293 cells were transfected with the 3TP-Lux reporter plasmids and either a control vector or XIAP, with or without a dominant negative mutant of Smad4 (DN Smad4). The DN Smad4 mutation effectively blocked the activation of 3TP-Lux by XIAP (Fig. 5A) , suggesting that XIAP transduces signals from T␤RI through a Smad4-dependent pathway, and thus utilizes the known TGF-␤ signaling machinery. Similar results were obtained from coexpression of XIAP and DN Smad4 in HepG2 cells (data not shown).
Since XIAP has previously been identified as a TAB1-associated protein (28) , and since TAB1 is involved in activating TAK1 (43, 52, 53) , it seemed possible that the ability of XIAP to activate 3TP-Lux might require TAK1, as well as Smad4. To test this possibility, a dominant negative mutation of TAK1 (DN TAK1) that destroys its kinase activity (43, 52, 53) was utilized in 3TP-Lux reporter assays. XIAP activation of 3TP-Lux was not inhibited by the expression of DN TAK1 in 293 cells (Fig. 5B) . Therefore, XIAP-dependent activation of 3TP-Lux expression requires Smad4, but is independent of TAK1.
Activation of JNK by XIAP Is Both Smad4-and TAK1-dependent-Since XIAP utilizes a Smad-dependent pathway to activate TGF-␤-regulated gene transcription, the DN Smad4 expression vector was tested for its effect on XIAP-mediated JNK activation. DN Smad4 abrogated JNK activation by XIAP (Fig. 6A) , indicating that XIAP activates JNK in a Smad-dependent manner.
To determine the role of TAK1 on XIAP-induced JNK activation, DN TAK1 was coexpressed with XIAP, and lysates were evaluated for JNK activity. Interestingly, DN TAK1 blocked the activation of JNK by XIAP (Fig. 6B) , indicating that TAK1 is involved in JNK activation by XIAP. These data suggest that JNK activation can be distinguished from activation of the 3TP-Lux reporter by XIAP, because DN TAK1 did not inhibit XIAP-induced 3TP-Lux activation (Fig. 5B) .
Because the activation of JNK by XIAP was inhibited by DN TAK1, and TAK1 is known to activate the p38 pathway (54), the effects of the p38 inhibitors, SB203580 and SB202190, on JNK activation by XIAP were tested (Fig. 6C) . Neither inhibitor blocked the activation of JNK by XIAP. Rather, each p38 inhibitor augmented XIAP's ability to activate JNK. These data suggest that JNK activation by XIAP is not the result of p38 activation.
To determine which domains of XIAP are involved in the activation of JNK, C-terminal deletions of XIAP were tested for their ability to activate JNK. The ⌬RING and 3xBIR constructs were able to activate JNK to levels equal to that of full-length XIAP, indicating that the BIR domains of XIAP are necessary and sufficient for JNK activation (Fig. 6D) . These data also suggest that, although the C-terminal RING finger domain of XIAP is necessary for activation of the 3TP-lux reporter, it is not required for activation of JNK. Thus, distinct domains of XIAP are involved in the activation of TGF-␤-responsive gene activity and JNK activation.
XIAP Activates NF-B-dependent Transcription through a Smad-dependent, but TAK1-independent
Pathway-A recent report indicated that TGF-␤ transactivates B sites in a Smaddependent manner (55) . Therefore, XIAP was examined to determine whether its ability to activate NF-B was also Smaddependent. XIAP was co-expressed in 293 cells with a reporter construct containing tandem B sites (2B-luc), with or without the DN Smad4 expression vector. Activation of NF-B by XIAP was blocked by co-expression of DN Smad4 (Fig. 7A) , suggesting that XIAP activates B-dependent gene expression in a Smad-dependent manner. To further characterize this pathway, the effects of DN TAK1 on the activation of 2B-luc by XIAP were evaluated. Interestingly, DN TAK1 did not inhibit the activation of 2B-luc by XIAP (Fig. 7B) . These data are similar to results obtained with the 3TP-Lux reporter, in that activation of both reporters by XIAP can be blocked by co-expression with DN Smad4 but not DN TAK1 (Fig. 5) . These data also support the observation that the ability of XIAP to activate transcription is separate from that of JNK activation, because DN TAK1 blocked JNK activation by XIAP (Fig. 6B) .
To determine the domains of XIAP required for the activation of NF-B, luciferase activity was evaluated from lysates of 293 cells transfected with the 2B-luc reporter plasmid and either full-length XIAP or the ⌬RING and 3xBIR mutants (Fig.  7C) . Full-length XIAP significantly activated the 2B-luc reporter, but neither the ⌬RING nor the 3xBIR deletion mutants were capable of this transactivation. These data are similar to those obtained for the 3TP-Lux reporter and suggest that the C-terminal domains of XIAP are required for transcriptional activation of either promoter by this protein.
XIAP Does Not Directly Associate with Smad4 -To test for a possible interaction between XIAP and Smad4, 293 cells were transfected with epitope-tagged Smad4 and GST-XIAP. XIAP is known to associate with itself; therefore, XIAP was used as a control for these experiments. Coprecipitations were performed, and Smad4 did not coprecipitate with GST-XIAP or with the GST control vector, whereas XIAP coprecipitated with GST-XIAP (Fig. 8) . These data suggest that XIAP does not directly associate with Smad4. However, an indirect association between these proteins cannot be ruled out.
The Anti-apoptotic Properties of XIAP Are Independent of Both Smad4 and TAK1-To investigate whether the anti-apoptotic properties of XIAP are dependent on either Smad4 or TAK1, the ability of XIAP to suppress Bax-induced apoptosis was examined in the presence of DN Smad4 or DN TAK1. Human embryonic kidney 293 cells were transfected with expression vectors encoding Bax, a pro-apoptotic member of the Bcl-2 family (56), along with XIAP and DN Smad4 or DN TAK1. Cell lysates were prepared, and the ability of XIAP to inhibit caspase activity was evaluated with a fluorogenic substrate AFC-DEVD as a measure of caspase activity (Fig. 9) . Neither DN Smad4 (Fig. 9A) nor DN TAK1 (Fig. 9B) had any affect on the ability of XIAP to inhibit caspase activity, suggesting that the anti-apoptotic properties of XIAP, at least against Bax-induced death, are independent of its roles in both JNK activation and TGF-␤-regulated signal transduction.
DISCUSSION
Although the IAP gene family was initially discovered based on the antiapoptotic properties of several of its members (7, 8) , a number of subsequent findings raised the possibility that they may play multiple roles within the cell. The data presented here reveal an involvement of XIAP in signal transduction mediated by TGF-␤. XIAP was found to co-localize (Fig. 2 ) and to associate with the TGF-␤ type I receptor, as well as other members of the TGF-␤ receptor superfamily, including ALK1 and ALK4 (Fig. 1A) . Moreover, the ability to interact with these receptors was unique to XIAP and not shared by the related apoptotic inhibitors c-IAP1 and c-IAP2 (Fig. 3A) . This superfamily of receptor serine/threonine kinases is activated by TGF-␤, activins, and BMPs, as well as other ligands, and utilizes a common pathway for signaling that involves ligandspecific type II receptors, which recruit a type I receptor to the complex upon ligand binding. The type II receptor phosphorylates the type I receptor, which in turn phosphorylates a pathway-specific Smad protein (33). This phosphorylated Smad can then associate with the common mediator, Smad4, which is involved in signaling through all pathways within the TGF-␤ superfamily. This complex then translocates to the nucleus, where it participates in various transcriptional complexes of specific DNA binding ability (30, 35, 57) .
Several TGF-␤-responsive promoters have been identified. These include PAI-1 and fibronectin (58, 59) , as well as collagen type I and type VII (60, 61) . Smad-binding elements have been identified in several of these promoters, including the PAI-1 promoter. However, Smads have a relatively low binding affinity and specificity and frequently regulate transcription by functional cooperation with various transcription factors bound to adjacent sites, or by direct association with DNA-bound transcription factors. For example, Smad3 and Smad4 interact with the Jun family of transcription factors and synergistically activate AP-1 promoter sequences (36, 62) . Likewise, an NF-B site, located in the 3Ј enhancer region of junB, has been identified as a TGF-␤-responsive site (55) . Activation of this site by TGF-␤ required an intact NF-B pathway and was mediated by Smad family members through direct interactions between Smad proteins and the NF-B subunit.
Data presented here suggest that XIAP is involved not only in the activation of a TGF-␤-responsive promoter, 3TP-Lux (Fig. 4) , which contains both PAI-1 and collagenase promoter elements (31) , but also in the activation of both JNK and NF-B (Fig. 6) , transcriptional mediators of TGF-␤ signaling. Activation of all three pathways was efficiently blocked by co-expression of DN Smad4 along with XIAP, indicating that XIAP utilizes a Smad-dependent pathway for activation of not only a TGF-␤-responsive promoter (Fig. 5A ), but also of JNK (Fig. 6A) and NF-B (Fig. 7A) . These data suggest a role for XIAP at a point upstream of Smad4 signaling.
Since XIAP activated these signaling pathways in a Smad4-dependent manner, it is possible that overexpression of wild type Smad4 would enhance this activation. However, data suggest that it is the amount of activated Smad4 present in the cell, and not the absolute levels of protein that affect Smad-dependent pathways (36, 63, 64) . Also, the cell lines utilized in this study express very high levels of endogenous Smad4, and it is therefore unlikely that Smad4 is limiting in any of these responses. Therefore, simple overexpression of Smad4 did not enhance signaling (data not shown).
Recent studies have revealed the existence of both Smad-dependent and Smad-independent pathways of JNK activation, in response to TGF-␤ (37). In the primary, Smad-independent pathway, JNK activity peaked within 10 min following stimulation with TGF-␤, whereas in the secondary, Smad-dependent pathway, JNK activity exhibited a slow, sustained peak over 12-16 h (37) . Because the results presented in Fig. 6A were obtained by cotransfection of XIAP and DN Smad4 and cells were harvested ϳ18 h after transfection, the possibility that XIAP may also activate JNK through the Smad-independent pathway cannot be eliminated.
Interestingly, the activation of JNK by XIAP was inhibited by DN TAK1 as well as by DN Smad4 (Fig. 6, A and B) , whereas both activation of NF-B (Fig. 7B ) and the TGF-␤-responsive promoter (Fig. 5B) were TAK1-independent. TAK1 is an upstream MAP3K that activates the p38 pathway (54) and has also been shown to be a mediator of TGF-␤-dependent signaling (43, 52) . Data presented here show that the ability of XIAP to activate JNK does not require the p38 pathway, despite the fact that DN TAK1 abrogates this activity (Fig. 6C) . TAK1 has previously been reported to indirectly associate with XIAP through mutual interaction with TAB1, the TAK1-binding protein (28) . Subsequently, XIAP was found to activate NF-B in a TAK1-dependent manner (20) in endothelial cells. In 293 cells, however, XIAP was found to activate NF-B independent of TAK1 (Fig. 7B) , and a recent report described the activation of NF-B-directed gene expression by TGF-␤ in a TAK1-independent fashion (55) , suggesting the existence of cell type variation of this pathway.
XIAP contains two distinct structural motifs found in several cellular IAPs. Three imperfectly repeated BIR domains are contained in the N terminus of XIAP. The BIR is the defining motif of the IAP family and is involved in caspase binding and inhibition (6) . The second motif is the C-terminal RING finger domain, which has been implicated in E2-dependent ubiquitin conjugation (13) . Deletion analysis of XIAP revealed that the BIR domain is involved in the association between XIAP and the T␤RI receptor, since deletions lacking the RING finger or both the RING and spacer regions were still able to associate with this receptor (Fig. 3B) . Likewise, JNK activation by XIAP required the BIR domain, but did not require the RING finger or spacer regions (Fig. 6B) . However, these same deletions revealed that both the activation of 3TP-Lux, the TGF-␤-responsive reporter, and the activation of NF-B by XIAP required the C-terminal RING and spacer regions, as deletion of these regions completely abrogated these functions. These data suggest that XIAP is multifunctional, with the N-terminal BIR domains participating in receptor association and JNK activation, and the C-terminal RING finger and spacer being involved in the activation of NF-B and TGF-␤-mediated transcription.
Further evidence for the multifunctionality of XIAP comes from the fact that, although its signaling properties were all Smad4-dependent, its ability to inhibit the enzymatic activity of caspases was completely independent of Smad4 (Fig. 9A) . These data were obtained by using Bax to induce apoptosis in 293 cells. Bax is known to promote the release of cytochrome c from the mitochondria, which, along with Apaf-1 and ATP/ dATP, catalyzes the processing of caspase-9 (65, 66) . Recently, TGF-␤ was found to activate the caspase cascade in a similar manner, through the release of cytochrome c and subsequent processing of caspase-9 (67) . XIAP has been shown to bind to, and inhibit the enzymatic activity of caspases-3, -7, and -9, all of which are activated by Bax as well as by TGF-␤ (67). Therefore, these functions are separable in that the signaling properties are Smad4-dependent, whereas the anti-apoptotic properties are Smad4-independent.
Recent reports have described the identification of a negative regulator of XIAP function, Smac/DIABLO (68, 69) , which has been shown to bind to XIAP and prevent its caspase inhibitory function (70) . It will be of great interest to determine whether Smac/DIABLO is capable of regulating the function of XIAP in the TGF-␤ signaling pathway.
Taken together, these data place XIAP at a central location for coordinating signaling from the TGF-␤ type I receptor for the activation of transcription, as well as the activation of both JNK and NF-B, co-factors involved in transcribing subsets of TGF-␤-responsive genes, since each of these activities is dependent on Smad4. Since no association was observed between XIAP and Smad4 (Fig. 8) , XIAP could be a signaling co-factor that is involved indirectly in the activation of Smad4, perhaps through association with another Smad protein, or other signaling intermediates. Further studies will be required to determine the mechanisms of these functional interactions.
